EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

EphA2 receptor tyrosine kinase (RTK) is highly expressed in breast tumor cells across multiple molecular subtypes and correlates with poor patient prognosis. In this study, the potential role of EphA2 in this clinically relevant phenomenon is investigated as metastasis of breast cancer to bone is a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JBMR Plus
Päätekijät: Vaught, David B, Merkel, Alyssa R, Lynch, Conor C, Edwards, James, Tantawy, Mohammed Noor, Hilliard, Timothy, Wang, Shan, Peterson, Todd, Johnson, Rachelle W, Sterling, Julie A, Brantley‐Sieders, Dana
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2021
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046157/
https://ncbi.nlm.nih.gov/pubmed/33869989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10465
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia